Thomas Urup

Rigshospitalet — Denmark

Medicine · Health Sciences

14h-index837citations68works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(59), Radiomics and Machine Learning in Medical Imaging(24), Cancer, Hypoxia, and Metabolism(19), Nanoplatforms for cancer theranostics(7), Brain Metastases and Treatment(7)

Publications68 total

Laser interstitial thermal therapy for IDH wild-type recurrent glioblastoma: a Scandinavian two-center cohort study
Acta Neurochirurgica·2026Open Access
P17.11.A SURVIVAL IMPACT AND PREDICTIVE FACTORS OF EPILEPSY IN GLIOBLASTOMA PATIENTS
Neuro-Oncology·2025Open Access
P03.06.A PERFUSION CHARACTERISATION OF GLIOMAS USING DYNAMIC [18F]FET PET/CT AND TIKHONOV MODEL-FREE DECONVOLUTION
Neuro-Oncology·2025Open Access
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study
Journal of Neuro-Oncology·2025Open Access
Bevacizumab rechallenge for recurrent glioblastoma - characterization of patients presenting multiple responses
2025Open Access
Abstract 69: Integrin αVβ3 targeted PET/CT for the assessment of bevacizumab therapy in patient-derived glioblastoma xenografts
Cancer Research·2025
Identifying targetable alterations predictive of distant progression in glioblastoma patients undergoing standard therapy
Neuro-Oncology Advances·2025· 1 citedOpen Access
P27.14.B OPTIMIZING GLIOBLASTOMA TRIAL DESIGN: A PROGNOSTIC MODEL HARNESSING REAL-WORLD DATA AND GENOMIC ALTERATIONS
Neuro-Oncology·2024Open Access
P09.14.B PREDICTION OF BEVACIZUMAB EFFICACY IN RECURRENT GLIOBLASTOMA PATIENTS BY EVALUATING [18F]-FET PET IMAGING RESPONSE
Neuro-Oncology·2024Open Access
P01.05.A DRUG-RESPONSE ANALYSIS AND SINGLE NUCLEUS RNA SEQUENCING ON PATIENT-DERIVED NEUROSPHERES TO REVEAL DRUG RESPONSE AND RESISTANCE MECHANISMS IN GLIOBLASTOMA
Neuro-Oncology·2024Open Access
P06.07.B IDENTIFYING TARGETABLE ALTERATIONS PREDICTIVE OF DISTANT PROGRESSION IN GLIOBLASTOMA PATIENTS UNDERGOING STANDARD THERAPY
Neuro-Oncology·2024Open Access
Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023
Neuro-Oncology Practice·2024· 5 citedOpen Access
Prognostic relevance of radiological findings on early postoperative MRI for 187 consecutive glioblastoma patients receiving standard therapy
Scientific Reports·2024· 7 citedOpen Access
BIOM-39. GENETIC VARIANTS ASSOCIATED WITH DISTANT RECURRENCE IN GLIOBLASTOMA PATIENTS TREATED WITH STANDARD THERAPY
Neuro-Oncology·2023Open Access
BIOM-24. PREDICTION OF DISTANT RECURRENCE IN GLIOBLASTOMA PATIENTS TREATED WITH STANDARD THERAPY
Neuro-Oncology·2023· 1 citedOpen Access
CTNI-32. IMPLEMENTING GENOMIC PROFILING AS STANDARD-OF-CARE FOR GLIOBLASTOMA PATIENTS
Neuro-Oncology·2023Open Access
Abstract 1046: Tracking tumor mutations in ctDNA through repetitive plasma samples in patients with newly diagnosed brain cancer
Cancer Research·2023
The Neurogenome study: Comprehensive molecular profiling to optimize treatment for Danish glioblastoma patients
Neuro-Oncology Advances·2023· 3 citedOpen Access
A systematic review of targeted therapy for vestibular schwannoma in patients with <i>NF2-</i>related schwannomatosis
Neuro-Oncology Advances·2023· 9 citedOpen Access
Predicting survival of glioblastoma from automatic whole-brain and tumor segmentation of MR images
Scientific Reports·2022· 23 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Hans Skovgaard Poulsen(41), Ulrik Lassen(31), Ib Jarle Christensen(22), Signe Regner Michaelsen(21), Kirsten Grunnet(21), Helle Broholm(18), Benedikte Hasselbalch(9), Anders Toft(8), Vincent Fougner(8), Vibeke Andrée Larsen(7), Michael Kosteljanetz(7), Ian Law(6), Shivani Chiranth(6), Dorte Schou Nørøxe(6), Lars Rønn Olsen(5), Søren Møller(5), Aida Muhic(5), Hans Erik Johnsen(5), Kirsten Grønbæk(5), Linn Gillberg(5)